Antibe Therapeutics Inc(Pre-Merger) T.ATE

Year End Q4 financials

[Duster340]

was june 30th last year. some insider buying before the blackout would be a good sign, but i do not expect to see any at this point. Q1 is aug/15th only 6 weeks after Q4, i do not see anything new unless we do  not get the update on the "IBD" program in Q4. Q2 is nov/15th i think just prior to the release is when  we see the stock price start to move,possibly we get a firm start date for P2.  

(the Company has selected lead and back-up candidates for its inflammatory bowel disease (“IBD”) program. These candidates are being evaluated in animal efficacy models with a patent application filing expected in the current quarter. Separately, Antibe is investigating a family of anti-inflammatory compounds that recently demonstrated promising results in an initial animal model; the Company expects to be in a position to make a more comprehensive announcement in the upcoming quarter.)

[MrMugsy]

Yes - Q4 financials and Update. I would assume an update focuses is on OTENA - hopefully comments on both acute and chronic. As for IBD - we might hear a patent application has occurred - if the stress test went well. We likely have the pills now - fingers crossed Planning for PK/PD - this is likely key for acute and chronic planning That's what I'd expect ... with the focus being OTENA.